What can we learn from phase II adjuvant trials in melanoma?

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Research programs

@article{7f9b8eb90c9e4186a5e162f47bcc6a5d,

title = "What can we learn from phase II adjuvant trials in melanoma?",

author = "U Keilholz and S Suciu and Lex Eggermont",

year = "2000",

language = "Undefined/Unknown",

volume = "83",

pages = "6--7",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "1",

}